Legal & General Group’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-3,994
| Closed | -$15K | – | 3487 |
|
|
2020
Q1 | $15K | Sell |
3,994
-1,134
| -22% | -$4.26K | ﹤0.01% | 3035 |
|
|
2019
Q4 | $31K | Buy |
5,128
+973
| +23% | +$5.88K | ﹤0.01% | 3034 |
|
|
2019
Q3 | $31K | Buy |
4,155
+695
| +20% | +$5.19K | ﹤0.01% | 2957 |
|
|
2019
Q2 | $47K | Buy |
+3,460
| New | +$47K | ﹤0.01% | 2805 |
|
|
2018
Q2 | – | Sell |
-2,436
| Closed | -$21K | – | 3401 |
|
|
2018
Q1 | $21K | Hold |
2,436
| – | – | ﹤0.01% | 3102 |
|
|
2017
Q4 | $30K | Buy |
2,436
+756
| +45% | +$9.31K | ﹤0.01% | 3064 |
|
|
2017
Q3 | $14K | Hold |
1,680
| – | – | ﹤0.01% | 3243 |
|
|
2017
Q2 | $30K | Buy |
+1,680
| New | +$30K | ﹤0.01% | 3044 |
|